QDEL
Price
$28.69
Change
+$0.69 (+2.46%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
1.95B
61 days until earnings call
XRAY
Price
$14.30
Change
-$0.02 (-0.14%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
2.85B
62 days until earnings call
Interact to see
Advertisement

QDEL vs XRAY

Header iconQDEL vs XRAY Comparison
Open Charts QDEL vs XRAYBanner chart's image
QuidelOrtho
Price$28.69
Change+$0.69 (+2.46%)
Volume$27.11K
Capitalization1.95B
DENTSPLY SIRONA
Price$14.30
Change-$0.02 (-0.14%)
Volume$55.54K
Capitalization2.85B
QDEL vs XRAY Comparison Chart in %
Loading...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QDEL vs. XRAY commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QDEL is a StrongBuy and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (QDEL: $28.00 vs. XRAY: $14.32)
Brand notoriety: QDEL and XRAY are both not notable
QDEL represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: QDEL: 84% vs. XRAY: 72%
Market capitalization -- QDEL: $1.9B vs. XRAY: $2.86B
QDEL [@Medical/Nursing Services] is valued at $1.9B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.86B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QDEL’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • QDEL’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than QDEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QDEL’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • QDEL’s TA Score: 5 bullish, 4 bearish.
  • XRAY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than XRAY.

Price Growth

QDEL (@Medical/Nursing Services) experienced а +9.12% price change this week, while XRAY (@Pharmaceuticals: Other) price change was +3.02% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.88%. For the same industry, the average monthly price growth was +6.74%, and the average quarterly price growth was +10.13%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.47%. For the same industry, the average monthly price growth was +5.74%, and the average quarterly price growth was +15.16%.

Reported Earning Dates

QDEL is expected to report earnings on Oct 29, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.85B) has a higher market cap than QDEL($1.95B). XRAY YTD gains are higher at: -23.002 vs. QDEL (-37.149). QDEL has higher annual earnings (EBITDA): 211M vs. XRAY (-689M). XRAY has more cash in the bank: 359M vs. QDEL (152M). XRAY has less debt than QDEL: XRAY (2.49B) vs QDEL (2.79B). XRAY has higher revenues than QDEL: XRAY (3.67B) vs QDEL (2.74B).
QDELXRAYQDEL / XRAY
Capitalization1.95B2.85B68%
EBITDA211M-689M-31%
Gain YTD-37.149-23.002162%
P/E RatioN/AN/A-
Revenue2.74B3.67B75%
Total Cash152M359M42%
Total Debt2.79B2.49B112%
FUNDAMENTALS RATINGS
QDEL vs XRAY: Fundamental Ratings
QDEL
XRAY
OUTLOOK RATING
1..100
6252
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is somewhat better than the same rating for QDEL (54). This means that XRAY’s stock grew somewhat faster than QDEL’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

XRAY's SMR Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

XRAY's Price Growth Rating (64) in the Medical Specialties industry is in the same range as QDEL (64). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

XRAY's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that XRAY’s stock grew similarly to QDEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QDELXRAY
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 17 days ago
67%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIUTX17.07N/A
N/A
Eaton Vance Dividend Builder I
VAFFX35.17N/A
N/A
Invesco American Franchise R6
GTMIX17.29N/A
N/A
GMO International Opportunistic Val III
GRETX11.54N/A
N/A
Goldman Sachs Real Estate Securities Inv
ARAIX78.80N/A
N/A
Ariel Fund Institutional

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
+0.83%
AZTA - QDEL
51%
Loosely correlated
-0.93%
XRAY - QDEL
50%
Loosely correlated
-0.07%
RVTY - QDEL
50%
Loosely correlated
+0.72%
DHR - QDEL
49%
Loosely correlated
+0.14%
A - QDEL
48%
Loosely correlated
+5.28%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.07%
NVST - XRAY
53%
Loosely correlated
+0.05%
QDEL - XRAY
50%
Loosely correlated
+0.83%
KIDS - XRAY
48%
Loosely correlated
-0.88%
STE - XRAY
46%
Loosely correlated
-1.69%
AZTA - XRAY
46%
Loosely correlated
-0.93%
More